Christoph Thorns

Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium

Daphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2007 · 305 citations · Full text

Medicine, Hematology, Pathology +17

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

German Ott, Marita Ziepert, Heike Horn et al. · Blood · 2010 · 202 citations · Full text

Veterinary Medicine, Hematology, Oncology +15

MicroRNA signatures characterize diffuse large B‐cell lymphomas and follicular lymphomas

Anja Roehle, Kai P. Hoefig, Dirk Repsilber et al. · British Journal of Haematology · 2008 · 193 citations · Full text

Life Sciences, Hematology, Oncology +16

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

Gilles Salles, Daphne de Jong, Wanling Xie et al. · Blood · 2011 · 191 citations · Full text

Medicine, Oncology, Pathology +17

Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

Daphne de Jong, Wanling Xie, Andreas Rosenwald et al. · Journal of Clinical Pathology · 2008 · 169 citations · Full text

Medicine, Hematology, Pathology +17